Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

Case study | 2023
Hospitals, Withdrawal, About prescribers, Clinical guidance

The study's aim is to identify whether the location of a drug exchange, specifically the dark web, influences public preferences for drug policy and police resourcing.

Original research | 2023
Policy/Regulatory, Illegal drugs, Legal system/law enforcement

We aimed to compare more recent statewide hospitalization rates for drug use-associated infective endocarditis (DUA-IE) in females versus males and contextualize them among other drug-related harms

Original research | 2023
Injecting drugs, Sex/Gender , Outcomes

The goal of the present study was to evaluate the association between the use of different substances and the risk of substance use disorder (SUD) while accounting for polysubstance use.

Original research | 2023
Illegal drugs, About PWUD
Guidelines | 2023
About prescribers, Withdrawal, Clinical guidance

We evaluate current trends in mortality for treatment-seeking older adults (OAs; age 55+ years).

Original research | 2023
Mortality, Substitution/OAT

This study investigates mortality risk associated with use of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment (OAT) among people with opioid dependence (PWOD).

Original research | 2023
Mortality, Substitution/OAT, About PWUD

The importance of social network influence on disease transmission is well established, yet the interplay between harm reduction and network structures is, generally, not well understood.

Original research | 2023
Substitution/OAT, About PWUD
Rapport | 2023
l'approvisionnement plus sécuritaire, la base de donnés probantes
Infographic | 2023
Overdose, Clinical guidance, Harm reduction
Guidelines | 2023
Overdose, Clinical guidance

Fueled by misinformation, fentanyl panic has harmed public health through complicating overdose rescue while rationalizing hyper-punitive criminal laws, wasteful expenditures, and proposals to curt

Original research | 2020
Overdose, Evidence base, Advocacy, Barriers and enablers
Commentary | 2017
Harm reduction, Policy/Regulatory
Letter | 2018
Chronic pain, About prescribers, Advocacy, Policy/Regulatory
Lit review | 2023
Commentary | 2023
Clinical guidance, Harm reduction, Wrap-around services, About PWUD

We sought to examine changes in health service use and incident cases of psychotic disorder following cannabis legalization, during a period of tight restrictions on retail stores and product types

Original research | 2023
Decriminalization/legalization, Outcomes, Hospitals, Mental health

Opioid overdose is the second leading cause of accidental death. Safe Consumption Sites (SCSs) are very effective harm reduction, but skepticism persists in the U.S. In four U.S.

Original research | 2023
SCS/OPS, Hesitancy of prescribers , Advocacy
Report | 2023
Mortality, Overdose, Policy/Regulatory, Safer supply, Decriminalization/legalization

Refine Your Search